Showing results (1-10 of 179) with videos related to
Sort By:
Pageof 18
Cancer Treatment Reports|April 1, 1980
Increased urinary beta 2-microglobulin after cancer chemotherapyJ J Fleming, L Parapia, D B Morgan, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1980
Renal tubular damage without glomerular damage after cytotoxic drugs and aminoglycosidesJ J Fleming, J A Child, E H Cooper, et al.Hematological Oncology|November 1, 1992
A pilot study of ChlOPhEPP-B--a weekly regimen for patients with untreated advanced or recurrent Hodgkin's diseaseG M Smith, D Wright, J A Child, et al.Hematological Oncology|July 1, 1991
Twin-track studies of ifosfamide and mitoxantrone (I-M) in recurrent high grade non-Hodgkin's lymphoma and Hodgkin's disease. Yorkshire Regional Lymphoma and Central Lymphoma GroupsJ A Child, A V Simmons, D L Barnard, et al.Hematological Oncology|July 1, 1990
Ifosfamide and mitoxantrone (I-M) in relapsed and refractory high grade non-Hodgkin's lymphoma and Hodgkin's diseaseG J Dovey, J A Child, A V Simmons, et al.Journal of Clinical Pathology|July 29, 2005
Change of pathology request forms can reduce unwanted requests and testsJ Bailey, A Jennings, L ParapiaEye (London, England)|February 7, 2001
Familial thrombophilia and retinal vein occlusionO Backhouse, L Parapia, I Mahomed, et al.Hematological Oncology|October 1, 1984
Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseasesJ A Child, M R KushwahaHematological Oncology|January 1, 1989
Pulsed high dose oral prednisolone in relapsed or refractory multiple myelomaD R Norfolk, J A ChildAnnals of Clinical Biochemistry|January 1, 1978
Intraperson variability. Magnitude, source, and influence on interpretation and diagnosisD B MorganPageof 18